PD-1 is an inhibitory receptor expressed on activated T cells, B cells, and natural killer cells, which is engaged by its major ligand PD-L1 expressed on tumor cells to suppress the T-cell-mediated cancer killing effect [2]. The gene discussed is CD274; the disease is neoplasm.